broad spectrum anti-TAR DNA-binding protein oligomer (Treventis)

N/A

Report date: 2025/01/26 18:26:52
NME

Base Information

Drug Namebroad spectrum anti-TAR DNA-binding protein oligomer (Treventis)
Drug Alias NameBroad Spectrum TDP Oligomer Inhibitor (Treventis)amyotrophic lateral sclerosis therapeutics (Treventis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTreventis Corp
China Registration ClassN/A

Develop Information

Active CompaniesTreventis Corp
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A